Literature DB >> 8740055

Are benzodiazepines antidepressants?

G Laakmann, M Faltermaier-Temizel, S Bossert-Zaudig, T Baghai.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8740055     DOI： 10.1007/bf02246673

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  The use of benzodiazepines in depression.

Authors:  D A Johnson
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

2.  History of benzodiazepine dependence.

Authors:  M Lader
Journal:  J Subst Abuse Treat       Date:  1991

Review 3.  Clinical uses of benzodiazepines.

Authors:  L E Hollister; B Müller-Oerlinghausen; K Rickels; R I Shader
Journal:  J Clin Psychopharmacol       Date:  1993-12       Impact factor: 3.153

4.  Treatment received by depressed patients.

Authors:  M B Keller; G L Klerman; P W Lavori; J A Fawcett; W Coryell; J Endicott
Journal:  JAMA       Date:  1982-10-15       Impact factor: 56.272

5.  Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant.

Authors:  W A Nolen; P M Haffmans; P F Bouvy; H J Duivenvoorden
Journal:  J Affect Disord       Date:  1993-07       Impact factor: 4.839

6.  Benzodiazepine dependence.

Authors:  M Lader
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1984       Impact factor: 5.067

7.  Are tricyclic antidepressants useful for mild depression? A placebo controlled trial.

Authors:  E S Paykel; P Freeling; J A Hollyman
Journal:  Pharmacopsychiatry       Date:  1988-01       Impact factor: 5.788

Review 8.  A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.

Authors:  J M Jonas; M S Cohon
Journal:  J Clin Psychiatry       Date:  1993-10       Impact factor: 4.384

9.  Prescription and misuse of benzodiazepines in the Federal Republic of Germany.

Authors:  B Müller-Oerlinghausen
Journal:  Pharmacopsychiatry       Date:  1986-01       Impact factor: 5.788

10.  Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.

Authors:  G Laakman; M Faltermaier-Temizel; S Bossert-Zaudig; T Baghai; G Lorkowski
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530
  10 in total
  4 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

2.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

Review 3.  [Core symptoms of depression. Effectiveness of antidepressant therapy].

Authors:  J Damm; D Eser; C Schüle; H-J Möller; R Rupprecht; T C Baghai
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

4.  Effects of different antidepressant treatments on the core of depression.

Authors:  Thomas C Baghai; Daniela Eser; Hans-Jürgen Möller
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.